PAncreatic neuroeNDocrine tumOr pAtients

Intervention study to improve Quality of Life in patients with small (<2 cm) pancreatic neuroendocrine tumors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28258

Enrollment

100

Registered

2021-07-02

Start date

2021-07-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic neuroendocrine tumors

Interventions

Providing a supportive care intervention to the second cohort

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosed with pancreatic NET on at least 2 imaging modalities - Patients >18 years - Able to read and write in Dutch/English

Exclusion criteria

Exclusion criteria: - Distant metastasis - Hereditary syndromes - Functioning pNET (insulinoma, gastrinoma etc) - pNET grade 3 according to 2010/2017 WHO grading system

Design outcomes

Primary

Measure	Time frame
Quality of life	—

Secondary

Measure	Time frame
Protocol adherence, feasibility and adherence to supportive care program, tumor-related outcomes	—

Contacts

Public ContactElisabeth Nieveen van Dijkum

Department of Surgery, Amsterdam UMC

e.j.nieveenvandijkum@amsterdamumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)